<![CDATA[RAIR Thyroid Cancer Research]]> https://rss.com/podcasts/rair-thyroid-cancer-research This podcast is dedicated to RAIR Thyroid Cancer research.

]]> RSS.com 2026.305.91805 Wed, 11 Mar 2026 18:19:34 GMT en e4da6d80-44d7-500c-9063-dc24878cbea0 https://media.rss.com/rair-thyroid-cancer-research/20260121_040150_34bc3d108df7170971b238ada45aac97.jpg RAIR Thyroid Cancer Research https://rss.com/podcasts/rair-thyroid-cancer-research yes John Londt John Londt false episodic podcast Oconomowoc, Oconomowoc, Waukesha County, Wisconsin, 53066, USA false <![CDATA[RAIR Thyroid Cancer Research Summary - February 2026]]> Here are the direct links to the February 2026 research and trials:

]]> https://rss.com/podcasts/rair-thyroid-cancer-research/2620846 496315c7-c75f-436c-8e6b-35ce64ea1f42 1238 full 1 1 4 4 false Wed, 11 Mar 2026 18:19:32 GMT false <![CDATA[Stereotactic Radiotherapy for Oligometastatic RAIR Thyroid Cancer]]>
  • Definitive Radiotherapy for Oligometastatic and Oligoprogressive Thyroid Cancer: A Potential Strategy for Systemic Therapy Deferral (2024)
  • Stereotactic Body Radiotherapy for Extracranial Oligometastatic Disease from Head and Neck Primary Cancers: A Systematic Review and Meta-Analysis
  • The Role of Stereotactic Radiotherapy in Deferring the Need for Systemic Therapies in Patients with Progressive Oligometastatic Iodine-Refractory Thyroid Cancer
  • Oligometastatic disease from differentiated thyroid cancer: best treatment schemes
  • Stereotactic Radiotherapy for Oligometastatic Head and Neck Cancers NotebookLM
    • ]]>     https://rss.com/podcasts/rair-thyroid-cancer-research/2544274 72b4ea4d-d022-4855-b3a4-3844bae9f355 702 full 1 1 3 3 false Thu, 12 Feb 2026 15:07:25 GMT false     <![CDATA[RAIR Thyroid Cancer Research (January 30th, 2026)]]>
  • Advances in Immunotherapy for Thyroid Malignancies: https://www.frontiersin.org/journals/medicine/articles/10.3389/fmed.2026.1754058/full
  • "Living Sentinel" Implant for Continuous Thyroid Monitoring: https://www.cmu.edu/news/stories/archives/2026/january/inside-cmus-push-to-transform-treatment-for-cancer-organ-failure-and-chronic-disease
  • Fatty Acid Metabolism Drives Bone Metastasis: https://www.mdanderson.org/cancerwise/new-research-advances-in-our-understanding-of-cancer-metabolism.h00-159852189.html
  • Cryoablation of Bone Metastases in Thyroid Cancer: https://pubmed.ncbi.nlm.nih.gov/41543023/
  • Sugary Drinks Reprogram Metabolism to Drive Metastasis: https://www.mdanderson.org/cancerwise/new-research-advances-in-our-understanding-of-cancer-metabolism.h00-159852189.html
  • AI in Screening Cuts Interval Cancer Rates by 12%: https://www.theguardian.com/science/2026/jan/29/ai-use-in-breast-cancer-screening-cuts-rate-of-later-diagnosis-by-12-study-finds
  • First Immunotherapy (Retifanlimab) Recommended for Advanced Anal Cancer: https://www.ema.europa.eu/en/news/first-immunotherapy-based-treatment-recommended-advanced-anal-cancer
  • Circulating Tumor DNA (ctDNA) in Germ Cell Tumors: https://ascopubs.org/journal/jco
  • Pancreatic Cancer’s "Sugar Cloak" Decoded: https://news.northwestern.edu/
  • Nuvalent "OnTarget 2026" Plan for RET Inhibitors: https://investors.nuvalent.com/
    • ]]>     https://rss.com/podcasts/rair-thyroid-cancer-research/2506981 3d404b0d-7623-4ce7-927b-fe6f6596a8be 1047 full 1 1 2 2 false Fri, 30 Jan 2026 16:41:55 GMT false     <![CDATA[Top 10 Research Papers: RAIR Thyroid Cancer (January 21, 2026 Update)]]> * Study identifies patients who would benefit from redifferentiation therapy for thyroid cancer

    https://www.mayoclinic.org/medical-professionals/endocrinology/news/study-identifies-patients-who-would-benefit-from-redifferentiation-therapy-for-thyroid-cancer/mac-20592451

    * BRAF and MEK Inhibition Beyond Dabrafenib-Trametinib in Advanced Thyroid Cancer

    https://www.frontiersin.org/journals/endocrinology/articles/10.3389/fendo.2026.1694805/full

    * Clinical Outcomes of Radioactive Iodine Redifferentiation Therapy in Previously Iodine Refractory Differentiated Thyroid Cancers

    https://pubmed.ncbi.nlm.nih.gov/37917101/

    * Off-Label Treatment Offers Hope for Patients With Rare Medullary Thyroid Cancer

    https://advances.massgeneral.org/oncology/article.aspx?id=1608

    * Redifferentiation Effect of Larotrectinib for NTRK Fusion-Positive Pediatric Thyroid Cancer

    https://pmc.ncbi.nlm.nih.gov/articles/PMC12209784/

    * Pilot Study of BRAF or MEK Inhibition to Restore Iodine Uptake (NCT04554680)

    https://clinicaltrials.gov/study/NCT04554680

    * Lutathera (177Lu-DOTATATE) Orphans: State of the Art and Future Application of Radioligand Therapy

    https://www.researchgate.net/publication/369730901_Lutathera_Orphans_State_of_the_Art_and_Future_Application_of_Radioligand_Therapy_with_Lu-DOTATATE

    * Identification of new small molecules for selective inhibition of SERCA 1 in patient-derived metastatic papillary thyroid cancer

    https://www.researchgate.net/publication/388836405_Identification_of_new_small_molecules_for_selective_inhibition_of_SERCA_1_in_patient-derived_metastatic_papillary_thyroid_cancer

    * Clinical Indications for Treatment with Multi-Kinase Inhibitors in Patients with RR-DTC

    https://www.mdpi.com/2072-6694/13/9/2279

    * A TIMELESS link to dedifferentiation in thyroid cancer

    https://joe.bioscientifica.com/downloadpdf/view/journals/joe/267/1/JOE-25-0136.pdf

    ]]>     https://rss.com/podcasts/rair-thyroid-cancer-research/2475295 aa0e0340-13b5-4a53-b0a2-baa17d83c68c 1118 full 1 1 1 1 false Wed, 21 Jan 2026 16:23:26 GMT false